The role of endocannabinoid pathway in the neuropathology of Alzheimer’s disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer’s disease?
Shivanshu Bajaj, Shreshta Jain, Preeti Vyas, Sandhya Bawa, Divya Vohora
Topics & Concepts
Endocannabinoid systemNeuropathologyNeuroscienceMonoacylglycerol lipaseAlzheimer's diseaseDiseaseCognitive impairmentMedicineCognitionPsychologyInternal medicineReceptorCannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior